Tuesday, December 23, 2025

Advisors Target Diversification in 2026 Strategies as Mag 7 Risk Rises

If 2025 ends strong, it will be the third straight year that the S&P 500 has notched double-digit gains. Not too shabby.

But that has many advisors worried about valuations in the large-cap space, especially in technology stocks connected to artificial intelligence. The Magnificent Seven, including Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla, now comprise one-third of that index’s market value. Some advisors are looking to diversify away from those names, and note that clients are worried that the market is due to correct. After all the hand-holding, however, advisors should remind clients why diversification matters to their financial plans, said Patrick Runyen, director of organic growth at Modera Wealth Management. He’s been reducing large-cap and international exposure in order to rebalance after this year’s run-up in both sectors.

“What we’re talking about with clients is keeping the diversified strategy in place and selling high and buying low on the margins,” he said.

SUBSCRIBE:  Receive more of our free Advisor Upside newsletter. READ ALSO: Schwab Scraps its Premium Robo Advisor Platform and Are Model Portfolios Key to Alt Adoption?

For many advisors, the first step is trimming exposure to the Mag 7 names, even if that means selling some of this year’s best-performing companies. “Almost at this point, it represents an asset class because it’s so demonstrably different than other equities,” said Bill Harris, CEO at Evergreen Wealth. “It’s not a diversified position … It’s a high-risk position, so if you’re looking for risk-adjusted return, you ought to move away from it. But that doesn’t mean get out.”

He remains invested in large-cap stocks but is breaking up the S&P 500 index into individual securities to modify exposure to the Mag 7. “You’ve got hundreds of individual securities, (so) you can do a heck of a lot better job with tax-related things such as tax-loss harvesting or asset location across taxable and tax-deferred accounts,” he said.

On the flip side, Steve Conners, president of Conners Wealth Management, said he’s looking at the large cap healthcare sector, particularly at pharmaceuticals and biotechnology. “The artificial intelligence theme has left them mostly ignored. Valuations are still attractive at current levels,” he said. He is avoiding health insurers in the broader healthcare space, however, saying they remain under too much pressure with the focus on rising health insurance premiums. “I’m not really interested in being the hero on United Healthcare or any of the health insurers.”

Source link

Hot this week

Topics

Related Articles

Popular Categories